| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $0.9B | $1.5B | $1.5B | $1.2B | $0.3B | $0.2B |
| Cost of Revenue | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.0B | $0.2B | $0.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.3B | $-2.4B | $-0.6B | $0.9B | $0.7B | $0.4B | $0.1B | $0.1B |
| EPS (Basic) | $-0.46 | $-4.02 | $-0.93 | $1.50 | — | $0.81 | $0.26 | $0.21 |
| EPS (Diluted) | $-0.46 | $-4.02 | $-0.93 | $1.50 | — | $0.81 | $0.26 | $0.21 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.0B | $14.3B | $18.3B | $19.7B | $20.5B | $16.8B | $14.5B | $8.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.3B | $0.3B | $0.2B | $0.5B | $0.5B | $1.5B | $0.8B |
| Total Liabilities | $10.4B | $9.5B | $10.7B | $11.1B | $12.1B | $9.5B | $7.4B | $4.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.6B | $4.8B | $7.6B | $8.6B | $8.4B | $7.3B | $7.0B | $4.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.5B | $0.7B | $0.8B | $0.6B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.3B | $1.3B | $0.5B | $0.4B | $-3.9B | $-2.9B | $-4.9B | $0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $-1.5B | $-1.0B | $-1.3B | $2.9B | $1.4B | $5.0B | $-0.3B |